Max Healthcare Institute Ltd (MAXHEALTH) — shareholding pattern, promoter holding, financials and share price
About Max Healthcare Institute Ltd (MAXHEALTH)
Max Healthcare Institute Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as MAXHEALTH and on the BSE under scrip code 543220. Its ISIN is INE027H01010.
Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and super-speciality hospitals providing operation and management, medical services, clinical, radiology, pathology services and related healthcare services. [1]
Max Healthcare Institute Limited operates a network of multi‑speciality and super‑speciality hospitals, plus two strategic business units (Max Lab and Max@Home); the Group runs ~20 facilities with ~5,200 beds, combining owned, managed and partner hospitals across major Indian metros and select PPP arrangements in Punjab.
Q3 FY26 network gross revenue reached ₹2,608 crore (+10% YoY) with Network Operating EBITDA of ₹648 crore (+4% YoY) and Network PAT of ₹344 crore (+9% YoY) after two exceptional items totaling ₹55 crore, reflecting steady profitability despite payor and regulatory headwinds.
Listed peers in Hospital: Apollo Hospitals Enterprise Ltd, Fortis Healthcare Ltd, Aster DM Healthcare Ltd, Narayana Hrudayalaya Ltd, Global Health Ltd, Krishna Institute of Medical Sciences Ltd.
Valuation & Returns
10 Jul 2026At ₹1,108.15 a share on 10 Jul 2026, Max Healthcare Institute Ltd (MAXHEALTH) was valued at a price-to-earnings ratio of 74.77x against an industry P/E of 61.73x and a price-to-book of 10.04x on a book value of ₹110.42 per share as of Mar 2026. Solomo computes return on equity of 13.42% and return on capital employed of 13.43% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 74.77x
- Industry P/E
- 61.73x
- P/B
- 10.04x
- EPS (TTM)
- ₹14.82
- Book value / share
- ₹110.42
- ROE
- 13.42%
- ROCE
- 13.43%
- ROA
- 8.37%
- Debt / equity
- 0.32x
- Dividend yield
- 0.18%
- EBITDA margin
- 28.15%
- 52-week range
- ₹903.5 – ₹1,301.95
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Max Healthcare Institute Ltd (MAXHEALTH) reported revenue of ₹8,373 crore, net profit of ₹1,442 crore and earnings per share of ₹14.82. That compares with revenue of ₹7,028 crore and net profit of ₹1,076 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹2,143 crore and net profit ₹342 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 3,937 | 4,563 | 5,406 | 7,028 | 8,373 |
| Net profit (₹ cr) | 605 | 1,104 | 1,058 | 1,076 | 1,442 |
| EPS (₹) | 6.24 | 11.37 | 10.88 | 11.07 | 14.82 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 12.65% | 22.77% | 14.70% | 19.14% |
| Profit growth | - | - | 1.06% | 34.07% |
| Stock price CAGR | - | 33% | 22% | -13% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 23.71% of Max Healthcare Institute Ltd (MAXHEALTH) (unchanged from the previous quarter), foreign institutional investors (FII) hold 41.78% and domestic institutional investors (DII) hold 29.96%. Market capitalisation was ₹1,07,850 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Jun 2020.
Largest disclosed public shareholders in Jun 2026: Nps Trust A/C through various schemes 3.45%, New World Fund Inc 3.29%, Government Of Singapore 3.28%, Hdfc Mutual Fund through various schemes 3.04%, Life Insurance Corporation of India through various schemes 3%, SBI Mutual Fund through various schemes 2.55%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 23.71% | - | 41.78% | 29.96% | 76.29% |
| Mar 2026 | 23.71% | - | 45.39% | 26.32% | 76.29% |
| Dec 2025 | 23.72% | - | 50.55% | 21.2% | 76.28% |
| Sep 2025 | 23.74% | - | 51.8% | 20.03% | 76.26% |
| Jun 2025 | 23.74% | - | 54.76% | 17.42% | 76.26% |
| Mar 2025 | 23.74% | - | 54.74% | 17.58% | 76.26% |
| Dec 2024 | 23.74% | - | 56.93% | 15.55% | 76.26% |
| Sep 2024 | 23.74% | - | 57.29% | 15.14% | 76.26% |